KYTX SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0001493152-26-047551
KYTX filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 19, 2026. A Schedule 13G was filed regarding Kyverna Therapeutics, Inc. (KYTX), indicating a passive ownership position by an institutional or other holder. The stock moved +2.8% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Kyverna Therapeutics, Inc. (KYTX), indicating a passive ownership position by an institutional or other holder. The filing text provided does not disclose the holder's identity, ownership percentage, or share count.
Key details
How KYTX stock reacted
Close before
$5.67
Oct 16, 2026
First close after
+2.82%
$5.83
5 trading days
-4.94%
$5.39
Since filing
-13.93%
$4.88
✦ Ask GOAX AI about this filing — what it means for KYTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KYTX?
Click hereFrequently asked questions
What did KYTX file with the SEC on Oct 19, 2026?
KYTX filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Kyverna Therapeutics, Inc. (KYTX), indicating a passive ownership position by an institutional or other holder. The filing text provided does not disclose the holder's identity, ownership percentage, or share count.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did KYTX stock react to this filing?
KYTX closed at $5.67 before the filing and $5.83 on Oct 19, 2026 (+2.82%). Five trading days later: $5.39 (-4.94%).
Other KYTX SEC filings
- 8-K · Fda approvalSep 24, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · Material agreementJul 27, 2026
- 8-K · Material agreementJul 9, 2026
- 8-K · Board changeJun 2, 2026
- 8-K · Cfo changeMay 18, 2026
- 10-Q · SEC filingMay 12, 2026
- 8-K · SEC filingMay 12, 2026
- 8-K · Executive departureMay 4, 2026
Get alerts when KYTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days